Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics

With the deal, Rona Therapeutics is set to receive an upfront payment of $100 million and is eligible to receive up to $1.06 billion in potential milestone payments, as well as tiered royalties on global net sales.